October 28, 2016
Sanofi will accept epilepsy drug blame if court rules that way
Sanofi will accept any blame attributed to it by a court over the harmful effects…
Pharmaceuticals, Biotechnology and Life Sciences
Tag: Sanofi
October 27, 2016
Sanofi to participate in Zika vaccine development
Sanofi and its vaccines global business unit Sanofi Pasteur has agreed to participate…
July 29, 2016
Sanofi reports net income €1,158m, down 11.1%
“Second quarter financial performance was in-line with expectations.” – Olivier Brandicourt, Sanofi CEO
March 29, 2016
Sanofi poaches AstraZeneca scientist as new research head
drugmaker Sanofi has poached one of AstraZeneca’s top scientists to be its new research head in another high-profile departure for the British drugmaker.
March 16, 2016
Sanofi and DiCE Molecules Announce Research Collaboration
Sanofi and DiCE Molecules has announced a five-year global collaboration to discover potential new therapeutics for up to 12 targets that encompass all disease areas of strategic interest to Sanofi.
March 13, 2016
Sanofi and Regeneron in Phase 3 study shows sarilumab was superior to adalimumab for treating RA patients
Sanofi and Regeneron Pharmaceuticals, Inc. have announced that a Phase 3 monotherapy study met its primary endpoint demonstrating that sarilumab…
March 10, 2016
Sanofi welcomes new Executive Committee member
Sanofi welcomes new Executive Committee member
March 10, 2016
Sanofi and MSD/Merck in joint vaccines operations in Europe
Sanofi and MSD/Merck in joint vaccines operations in Europe
February 22, 2016
FDA Accepts Sanofi NDA for Combination of Insulin Glargine and Lixisenatide (diabetes)
The U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for Sanofi’s investigational fixed-ratio combination of basal insulin glargine 100 Units/mL and GLP-1 receptor agonist lixisenatide for the treatment of adults with type 2 diabetes.
January 6, 2016
Glenmark’s generic Multaq tablets wait for final FDA approval after tentative
Glenmark Pharmaceuticals Inc., has been granted tentative approval by the USFDA for its Dronedarone Tablets, 400 mg, the generic version…